Ra. Burger et al., SPONTANEOUS RELEASE OF INTERLEUKIN-6 BY PRIMARY CULTURES OF LYMPHOID AND TUMOR-CELL POPULATIONS PURIFIED FROM HUMAN OVARIAN-CARCINOMA, Journal of interferon & cytokine research, 15(3), 1995, pp. 255-260
Interleukin-6 (IL-6) is a cytokine that has been implicated as a growt
h factor in human ovarian carcinoma, yet the in vivo source of IL-6 in
patients remains undefined. We measured IL-6 by ELISA in cell-free as
cites (CFA) of 19 patients with ovarian carcinoma, IL-6 was detectable
in all samples (mean level 3.3 ng/mI). To identify the cellular sourc
e of IL-6, we measured this cytokine by ELISA in 24-48 h supernatants
of cultured lymphocyte-, macrophage-, and tumor cell-enriched populati
ons purified from three solid ovarian carcinomas by centrifugal elutri
ation. All cell populations spontaneously released IL-6; however, tumo
r eel and tumor-associated macrophage released levels of IL-6 that gre
atly exceeded those released by tumor-associated lymphocytes. Kinetic
studies revealed that IL-6 was detectable at 6 h and that levels incre
ased in all cultures examined over a 48 h time course. These data sugg
est that both tumor and infiltrating host cells may be the source of t
he high levels of IL-6 found in carcinomatous ascites. Furthermore, al
though all three cell types examined may contribute to IL-6 production
in patients with ovarian carcinoma, tumor cells are perhaps the most
clinically significant source.